Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gla-se (2 trials)
id93 (2 trials)
qtp104 (1 trial)
Tuberculosis (Phase 2)
Trials (3 total)
Trial APIs (3 total)